Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression

Journal of Cell Science

Volumn 127, Issue 8, 2014, Pages 1672-1683

  German, Alexandra E ^a,b   Mammoto, Tadanori ^b   Jiang, Elisabeth ^b   Ingber, Donald E ^b,c,d   Mammoto, Akiko ^b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HARVARD UNIVERSITY   (United States)

Author keywords

Angiogenesis; Cancer; Capillary endothelial cell; Motility; Neuropilin 2; Paxillin; VEGF

Indexed keywords

NEUROPILIN 2; PAXILLIN; VASCULOTROPIN; NEUROPILIN-2, HUMAN; PXN PROTEIN, HUMAN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADHESION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CONTROL; CAPILLARY ENDOTHELIAL CELL; CELL MIGRATION; CONTROLLED STUDY; FIBROBLAST; GROWTH REGULATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR VASCULARIZATION; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CELL MOTION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; LEWIS CARCINOMA; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA BLOOD VESSEL; TRANSPLANTATION; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

ANIMALS; CARCINOMA, LEWIS LUNG; CELL LINE, TUMOR; CELL MOVEMENT; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILIN-2; PAXILLIN; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84898913240     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.132316     Document Type: Article

References (61)

1. Abedi, H. and Zachary, I. (1997). Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J. Biol. Chem. 272, 15442-15451.
2. Bielenberg, D. R., Hida, Y., Shimizu, A., Kaipainen, A., Kreuter, M., Kim, C. C. and Klagsbrun, M. (2004). Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J. Clin. Invest. 114, 1260-1271.
3. Bielenberg, D. R., Pettaway, C. A., Takashima, S. and Klagsbrun, M. (2006). Neuropilins in neoplasms: expression, regulation, and function. Exp. Cell Res. 312, 584-593.
4. Brock, A. L. and Ingber, D. E. (2005). Control of the direction of lamellipodia extension through changes in the balance between Rac and Rho activities. Mol. Cell. Biomech. 2, 135-143.
5. Brown, M. C. and Turner, C. E. (2004). Paxillin: adapting to change. Physiol. Rev. 84, 1315-1339.
6. Carmeliet, P. (2005). Angiogenesis in life, disease and medicine. Nature 438, 932-936.
7. Carmeliet, P. and Jain, R. K. (2011). Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307.
8. Chen, J. Y., Tang, Y. A., Huang, S. M., Juan, H. F., Wu, L. W., Sun, Y. C., Wang, S. C., Wu, K. W., Balraj, G., Chang, T. T. et al. (2011). A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways. Cancer Res. 71, 473-483.
9. Chung, A. S. and Ferrara, N. (2011). Developmental and pathological angiogenesis. Annu. Rev. Cell Dev. Biol. 27, 563-584.
10. Deakin, N. O. and Turner, C. E. (2008). Paxillin comes of age. J. Cell Sci. 121, 2435-2444.
11. Deakin, N. O., Pignatelli, J. and Turner, C. E. (2012). Diverse roles for the paxillin family of proteins in cancer. Genes Cancer 3, 362-370.
12. Dike, L. E., Chen, C. S., Mrksich, M., Tien, J., Whitesides, G. M. and Ingber, D. E. (1999). Geometric control of switching between growth, apoptosis, and differentiation during angiogenesis using micropatterned substrates. In Vitro Cell. Dev. Biol. Anim. 35, 441-448.
13. Favier, B., Alam, A., Barron, P., Bonnin, J., Laboudie, P., Fons, P., Mandron, M., Herault, J.-P., Neufeld, G., Savi, P. et al. (2006). Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood 108, 1243-1250.
14. Geretti, E., Shimizu, A. and Klagsbrun, M. (2008). Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 11, 31-39.
15. Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D. et al. (2003). VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177.
16. Gluzman-Poltorak, Z., Cohen, T., Herzog, Y. and Neufeld, G. (2000). Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]. J. Biol. Chem. 275, 18040-18045.
17. Golubovskaya, V. M., Nyberg, C., Zheng, M., Kweh, F., Magis, A., Ostrov, D. and Cance, W. G. (2008). A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growth. J. Med. Chem. 51, 7405-7416.
18. Hagel, M., George, E. L., Kim, A., Tamimi, R., Opitz, S. L., Turner, C. E., Imamoto, A. and Thomas, S. M. (2002). The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol. Cell. Biol. 22, 901-915.
19. Huang, S. M., Hsu, P. C., Chen, M. Y., Li, W. S., More, S. V., Lu, K. T. and Wang, Y. C. (2012). The novel indole compound SK228 induces apoptosis and FAK/Paxillin disruption in tumor cell lines and inhibits growth of tumor graft in the nude mouse. Int. J. Cancer 131, 722-732.
20. Jagadeeswaran, R., Surawska, H., Krishnaswamy, S., Janamanchi, V., Mackinnon, A. C., Seiwert, T. Y., Loganathan, S., Kanteti, R., Reichman, T., Nallasura, V. et al. (2008). Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res. 68, 132-142.
21. Koch, S., Tugues, S., Li, X., Gualandi, L. and Claesson-Welsh, L. (2011). Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437, 169-183.
22. Kut, C., Mac Gabhann, F. and Popel, A. S. (2007). Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer. Br. J. Cancer 97, 978-985.
23. Lamalice, L., Le Boeuf, F. and Huot, J. (2007). Endothelial cell migration during angiogenesis. Circ. Res. 100, 782-794.
24. Li, S., Guan, J. L. and Chien, S. (2005). Biochemistry and biomechanics of cell motility. Annu. Rev. Biomed. Eng. 7, 105-150.
25. Lohela, M., Bry, M., Tammela, T. and Alitalo, K. (2009). VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 21, 154-165.
26. Mackinnon, A. C., Tretiakova, M., Henderson, L., Mehta, R. G., Yan, B. C., Joseph, L., Krausz, T., Husain, A. N., Reid, M. E. and Salgia, R. (2011). Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease. J. Clin. Pathol. 64, 16-24.
27. Madan, R., Smolkin, M. B., Cocker, R., Fayyad, R. and Oktay, M. H. (2006). Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma. Hum. Pathol. 37, 9-15.
28. Mammoto, A. and Ingber, D. E. (2009). Cytoskeletal control of growth and cell fate switching. Curr. Opin. Cell Biol. 21, 864-870.
29. Mammoto, A., Connor, K. M., Mammoto, T., Yung, C. W., Huh, D., Aderman, C. M., Mostoslavsky, G., Smith, L. E. and Ingber, D. E. (2009). A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457, 1103-1108.
30. Mammoto, A., Mammoto, T. and Ingber, D. E. (2012). Mechanosensitive mechanisms in transcriptional regulation. J. Cell Sci. 125, 3061-3073.
31. Murata, M., Kador, P. F. and Sato, S. (2000). Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells. J. Ocul. Pharmacol. Ther. 16, 383-391.
32. Nayal, A., Webb, D. J., Brown, C. M., Schaefer, E. M., Vicente-Manzanares, M. and Horwitz, A. R. (2006). Paxillin phosphorylation at Ser273 localizes a GIT1-PIX-PAK complex and regulates adhesion and protrusion dynamics. J. Cell Biol. 173, 587-589.
33. Neufeld, G., Kessler, O. and Herzog, Y. (2002). The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. Adv. Exp. Med. Biol. 515, 81-90.
34. Nishiya, N., Kiosses, W. B., Han, J. and Ginsberg, M. H. (2005). An alpha4 integrin-paxillin-Arf-GAP complex restricts Rac activation to the leading edge of migrating cells. Nat. Cell Biol. 7, 343-352.
35. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. and Folkman, J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
36. Parker, K. K., Brock, A. L., Brangwynne, C., Mannix, R. J., Wang, N., Ostuni, E., Geisse, N. A., Adams, J. C., Whitesides, G. M. and Ingber, D. E. (2002). Directional control of lamellipodia extension by constraining cell shape and orienting cell tractional forces. FASEB J. 16, 1195-1204.
37. Plotnikov, S. V., Pasapera, A. M., Sabass, B. and Waterman, C. M. (2012). Force fluctuations within focal adhesions mediate ECM-rigidity sensing to guide directed cell migration. Cell 151, 1513-1527.
38. Polacheck, W. J., German, A. E., Mammoto, A., Ingber, D. E. and Kamm, R. D. (2014). Mechanotransduction of fluid stresses governs 3D cell migration. Proc. Natl. Acad. Sci. USA [Epub ahead of print] doi: 10.1073/pnas.1316848111.
39. Salgia, R., Li, J. L., Ewaniuk, D. S., Wang, Y. B., Sattler, M., Chen, W. C., Richards, W., Pisick, E., Shapiro, G. I., Rollins, B. J. et al. (1999). Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility. Oncogene 18, 67-77.
40. Satchi-Fainaro, R., Mamluk, R., Wang, L., Short, S. M., Nagy, J. A., Feng, D., Dvorak, A. M., Dvorak, H. F., Puder, M., Mukhopadhyay, D. et al. (2005). Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 7, 251-261.
41. Sawada, Y. and Sheetz, M. P. (2002). Force transduction by Triton cytoskeletons. J. Cell Biol. 156, 609-615.
42. Sen, A., De Castro, I., Defranco, D. B., Deng, F. M., Melamed, J., Kapur, P., Raj, G. V., Rossi, R. and Hammes, S. R. (2012). Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J. Clin. Invest. 122, 2469-2481.
43. Sero, J. E., Thodeti, C. K., Mammoto, A., Bakal, C., Thomas, S. and Ingber, D. E. (2011). Paxillin mediates sensing of physical cues and regulates directional cell motility by controlling lamellipodia positioning. PLoS ONE 6, e28303.
44. Sero, J. E., German, A. E., Mammoto, A. and Ingber, D. E. (2012). Paxillin controls directional cell motility in response to physical cues. Cell Adh. Migr. 6, 502-508.
45. Shen, J., Samul, R., Zimmer, J., Liu, H., Liang, X., Hackett, S. and Campochiaro, P. A. (2004). Deficiency of neuropilin 2 suppresses VEGFinduced retinal neovascularization. Mol. Med. 10, 12-18.
46. Shimizu, A., Mammoto, A., Italiano, J. E., Jr, Pravda, E., Dudley, A. C., Ingber, D. E. and Klagsbrun, M. (2008). ABL2/ARG tyrosine kinase mediates SEMA3F-induced RhoA inactivation and cytoskeleton collapse in human glioma cells. J. Biol. Chem. 283, 27230-27238.
47. Short, S. M., Yoder, B. J., Tarr, S. M., Prescott, N. L., Laniauskas, S., Coleman, K. A., Downs-Kelly, E., Pettay, J. D., Choueiri, T. K., Crowe, J. P. et al. (2007). The expression of the cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective immunohistochemical study. Breast J. 13, 130-139.
48. Tachibana, K., Sato, T., D'Avirro, N. and Morimoto, C. (1995). Direct association of pp125FAK with paxillin, the focal adhesion-targeting mechanism of pp125FAK. J. Exp. Med. 182, 1089-1099.
49. Takashima, S., Kitakaze, M., Asakura, M., Asanuma, H., Sanada, S., Tashiro, F., Niwa, H., Miyazaki Ji, J., Hirota, S., Kitamura, Y. et al. (2002). Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc. Natl. Acad. Sci. USA 99, 3657-3662.
50. Tsubouchi, A., Sakakura, J., Yagi, R., Mazaki, Y., Schaefer, E., Yano, H. and Sabe, H. (2002). Localized suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and migration. J. Cell Biol. 159, 673-683.
51. Turner, C. E., Glenney, J. R., Jr and Burridge, K. (1990). Paxillin: a new vinculinbinding protein present in focal adhesions. J. Cell Biol. 111, 1059-1068.
52. Velasco-Velázquez, M. A., Salinas-Jazmín, N., Mendoza-Patiño, N. and Mandoki, J. J. (2008). Reduced paxillin expression contributes to the antimetastatic effect of 4-hydroxycoumarin on B16-F10 melanoma cells. Cancer Cell Int. 8, 8.
53. Wacker, A. and Gerhardt, H. (2011). Endothelial development taking shape. Curr. Opin. Cell Biol. 23, 676-685.
54. Wade, R., Bohl, J. and Vande Pol, S. (2002). Paxillin null embryonic stem cells are impaired in cell spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene 21, 96-107.
55. Wild, J. R., Staton, C. A., Chapple, K. and Corfe, B. M. (2012). Neuropilins: expression and roles in the epithelium. Int. J. Exp. Pathol. 93, 81-103.
56. Wozniak, M. A., Modzelewska, K., Kwong, L. and Keely, P. J. (2004). Focal adhesion regulation of cell behavior. Biochim. Biophys. Acta 1692, 103-119.
57. Xia, N., Thodeti, C. K., Hunt, T. P., Xu, Q., Ho, M., Whitesides, G. M., Westervelt, R. and Ingber, D. E. (2008). Directional control of cell motility through focal adhesion positioning and spatial control of Rac activation. FASEB J. 22, 1649-1659.
58. Yang, H. J., Chen, J. Z., Zhang, W. L. and Ding, Y. Q. (2010). Focal adhesion plaque associated cytoskeletons are involved in the invasion and metastasis of human colorectal carcinoma. Cancer Invest. 28, 127-134.
59. Yano, H., Mazaki, Y., Kurokawa, K., Hanks, S. K., Matsuda, M. and Sabe, H. (2004). Roles played by a subset of integrin signaling molecules in cadherinbased cell-cell adhesion. J. Cell Biol. 166, 283-295.
60. Yuan, L., Moyon, D., Pardanaud, L., Bréant, C., Karkkainen, M. J., Alitalo, K. and Eichmann, A. (2002). Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129, 4797-4806.
61. Zaidel-Bar, R., Milo, R., Kam, Z. and Geiger, B. (2007). A paxillin tyrosine phosphorylation switch regulates the assembly and form of cell-matrix adhesions. J. Cell Sci. 120, 137-148.